Skip to main content
OpenTrials
Completed

NCT Number: NCT07252024

Nurse-Led BIS-Guided Sedation Protocol in Pediatric Intensive Care

Pediatric intensive care sedation is traditionally based on subjective clinical scales. Bispectral Index (BIS) monitoring provides an objective EEG-based assessment of sedation depth. This prospective, two-center randomized controlled trial evaluates whether a nurse-led BIS-guided sedation protocol can reduce excessive or inadequate sedation, sedative medication exposure, withdrawal symptoms, and PICU length of stay in mechanically ventilated children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 month–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Behcet Uz Children's Hospital - Pediatric Intensive Care Unit

Izmir, Turkey (Türkiye)

About this study

This prospective, randomized (1:1) controlled trial was conducted in two tertiary PICUs in Turkey, including mechanically ventilated children aged 1 month to 18 years requiring continuous sedation. Patients were randomly assigned to:

Intervention Group: Nurse-led sedation titration using BIS values (target: light sedation 60-80, deep sedation 45-60) combined with SBS scores under physician supervision. Nurses received structured theoretical and practical training before trial initiation.

Control Group: Standard sedation protocol based solely on clinical sedation assessment without BIS-guided titration (BIS monitoring available but not used for titration).

Primary Outcome:

Percentage and duration of time spent outside the target BIS range

Total sedative medication dose (mg/kg/day equivalents)

Secondary Outcomes:

PICU length of stay

Mechanical ventilation duration

Withdrawal symptoms (WAT-1 score)

Results showed significantly reduced BIS out-of-target time, lower sedative drug exposure (midazolam, ketamine, dexmedetomidine), reduced withdrawal scores, and shorter PICU stay in the intervention group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 1 month and 18 years
  • Receiving invasive mechanical ventilation
  • Expected to require sedation for ≥24 hours
  • Hemodynamically stable at enrollment
  • BIS monitoring electrode placement feasible

Exclusion criteria

  • Use of neuromuscular blocking agents at enrollment
  • Mechanical ventilation expected to last <24 hours
  • Severe hemodynamic instability requiring escalating vasoactive support
  • Known neurological disorders that prevent reliable BIS interpretation (e.g., severe encephalopathy, epileptic burst suppression)
  • Facial burns or skin conditions preventing BIS electrode placement
  • Decision for palliative/comfort care only

Treatment and study plan

BIS-Guided Sedation Protocol

Behavioral

A structured sedation management protocol guided by Bispectral Index (BIS) monitoring and implemented by trained PICU nurses. The protocol includes BIS target ranges (light sedation 60-80; deep sedation 45-60), artifact recognition, standardized electrode placement, and stepwise titration of midazolam, ketamine, dexmedetomidine, or fentanyl according to predefined algorithms under physician supervision.

Primary outcomes

  1. Time Spent Outside BIS Target Range

    Time frame: First 72 hours of mechanical ventilation

    otal duration (in hours) during which BIS values remain outside the predefined sedation targets (light sedation: 60-80; deep sedation: 45-60). This measure reflects adequacy of sedation and protocol effectiveness.

  2. Cumulative Midazolam Dose

    Time frame: Up to 28 days or until extubation

    otal midazolam dose administered (mg/kg) during mechanical ventilation.

  3. Cumulative Ketamine Dose

    Time frame: Up to 28 days or until extubation

    Total ketamine dose administered (mcg/kg) during mechanical ventilation.

  4. Cumulative Dexmedetomidine Dose

    Time frame: Up to 28 days or until extubation

    Total dexmedetomidine dose administered (mcg/kg) during mechanical ventilation.

Secondary outcomes

  1. Withdrawal Severity (WAT-1 Score)

    Time frame: First 7 days of PICU stay

    Mean and peak WAT-1 scores assessed to determine iatrogenic withdrawal severity.

  2. PICU Length of Stay

    Time frame: Up to 28 days

    Total number of days from PICU admission to PICU discharge.

Sponsors and collaborators

Lead sponsor

Dr. Behcet Uz Children's Hospital

Other

Registry information

Official study title

Nurse-Led Bispectral Index (BIS)-Guided Sedation Protocol and Its Impact on Clinical Outcomes in Mechanically Ventilated Pediatric Intensive Care Patients: A Prospective, Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 26, 2025
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.